Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is GraniteShares 2x Long QCOM Daily ETF (QCML) Up +11.36% Today?

Why Is GraniteShares 2x Long QCOM Daily ETF (QCML) Up +11.36% Today?

Key Takeaways

  • The QCML ETF surged +11.36% to $22.84, up from a prior close of $20.51.
  • The primary catalyst was Qualcomm's renewal of its global patent license agreement with Apple, removing a key uncertainty over royalty revenue.
  • The fund's 2x daily leverage amplified the roughly 5.9% advance in Qualcomm (QCOM) shares.
  • Broader artificial-intelligence and semiconductor optimism provided additional support to the underlying stock.
  • As a single-stock leveraged ETF, QCML performance is driven almost entirely by Qualcomm's daily price action.
  • Investors are watching Qualcomm's earnings trajectory, AI-related design wins, and smartphone demand into the next quarter.

Opening Summary

The GraniteShares 2x Long QCOM Daily ETF (QCML) rallied sharply in today's session, climbing +11.36% to $22.84 from a prior closing price of $20.51. The fund seeks to deliver two times (200%) the daily percentage change of Qualcomm Incorporated (QCOM) common stock, using swaps and options to build that leveraged exposure. Today's outsized advance was powered by Qualcomm's announcement that it has renewed its global patent license agreement with Apple, combined with a broadly firmer tone across semiconductor and artificial-intelligence names.

What Drove the ETF Move Today

Apple Patent License Renewal

The dominant catalyst was Qualcomm's confirmation that it renewed its global patent license agreement with Apple, with the new arrangement taking effect April 1, 2027. The renewal resolves a lingering question over whether Apple, a major royalty contributor to Qualcomm's QTL licensing business, would remain a licensee. Analysts estimate the agreement generates roughly $1.5 billion to $1.7 billion in annual revenue, or about $1.25 to $1.50 in earnings per share, underscoring its significance to Qualcomm's financials. The removal of this uncertainty triggered strong buying in Qualcomm shares, which rippled directly into the leveraged QCML ETF.

Broad AI and Semiconductor Momentum

The move also reflected favorable market sentiment toward semiconductor and artificial-intelligence names. Wall Street advanced moderately on renewed AI enthusiasm, with chipmakers broadly supported as investors positioned around the ongoing build-out of AI infrastructure and edge computing. Qualcomm's expanding push into on-device AI, data-center inference, and partnerships with hyperscale customers reinforced the constructive backdrop for the stock and, by extension, for QCML.

Leverage Amplification

Because QCML is engineered to return twice the daily move of Qualcomm, a roughly 5.9% rise in the underlying stock translated into an approximately 11.4% advance in the fund. This leverage cuts both ways: it magnifies gains on up days and equally amplifies losses on down days, and it is designed for short-term, single-day objectives rather than buy-and-hold investing.

Which Holdings Contributed Most

QCML does not hold a diversified basket of stocks. It is a single-stock leveraged product whose performance is tied entirely to Qualcomm, achieved primarily through total return swaps and options rather than a large direct equity position. As a result, Qualcomm effectively accounts for all of the fund's directional exposure, and its move today was the sole engine of the ETF's performance. Apple's role is indirect but material: as a key royalty customer, Apple's continued licensing relationship supports a meaningful portion of Qualcomm's high-margin revenue.

Market Context and Trading Activity

The advance in QCML aligned with strength in the broader semiconductor complex and with a modestly positive session for technology-heavy indexes. The move also pushed the fund well above its recent trading range, reflecting renewed conviction in Qualcomm following the Apple announcement. Because the ETF's daily reset mechanism rebalances exposure each day, traders monitoring the fund tend to focus on the direction and volatility of Qualcomm's intraday and closing prices rather than traditional support and resistance levels on the ETF itself.

What Comes Next for QCML

The near-term path for QCML will hinge on Qualcomm's continued execution and the broader semiconductor cycle. Investors will monitor Qualcomm's quarterly earnings, smartphone demand trends, its automotive and Internet-of-Things segments, and the ramp of AI-related products such as data-center inference chips. Macroeconomic factors, including interest-rate expectations and consumer electronics demand, also carry weight. Because the fund is leveraged and resets daily, volatility and holding periods longer than a single session introduce compounding risks that investors should weigh carefully. No single day's move, including today's surge, is a reliable predictor of future performance.

Trending AI Robots

Tickeron's Trending AI Robots page highlights the platform's strongest-performing automated trading strategies under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, and only those delivering standout results are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols. Explore the Trending AI Robots page to discover the strategies currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: QCML

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for QCML turns positive, indicating new upward trend

QCML saw its Momentum Indicator move above the 0 level on August 31, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator turned positive. In 18 of the 19 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

QCML moved above its 50-day moving average on September 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for QCML crossed bullishly above the 50-day moving average on September 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +22.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where QCML advanced for three days, in 88 of 96 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 62 of 65 cases where QCML Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for QCML moved out of overbought territory on September 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 10 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QCML declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

QCML broke above its upper Bollinger Band on September 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Industry description

The investment seeks daily investment results, before fees and expenses, of 2 times (200%) the daily percentage change of the common stock of Qualcomm Incorporated. The fund is an actively managed exchange traded fund that attempts to replicate 2 times (200%) the daily percentage change of the underlying stock by entering into financial instruments such as swaps and options underlying stock as well as directly purchasing the underlying stock. The fund is non-diversified.
View a ticker or compare two or three
QCML
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
GraniteShares ETF Trust30 Vesey Street, 9th FloorNew York
Phone
N/A
Web
N/A
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.